thymidine has been researched along with Adenocarcinoma, Alveolar in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lee, CT | 1 |
| Park, KH | 1 |
| Adachi, Y | 1 |
| Seol, JY | 1 |
| Yoo, CG | 1 |
| Kim, YW | 1 |
| Han, SK | 1 |
| Shim, YS | 1 |
| Coffee, K | 1 |
| Dikov, MM | 1 |
| Carbone, DP | 1 |
| Han, T | 1 |
| Takita, H | 1 |
| Yuhas, JM | 1 |
| Toya, RE | 1 |
| Pazmiño, NH | 1 |
3 other studies available for thymidine and Adenocarcinoma, Alveolar
| Article | Year |
|---|---|
Recombinant adenoviruses expressing dominant negative insulin-like growth factor-I receptor demonstrate antitumor effects on lung cancer.
Topics: Adenocarcinoma, Bronchiolo-Alveolar; Adenoviridae; Animals; Carcinoma, Large Cell; Cell Division; Co | 2003 |
Immunologic impairment in bronchogenic carcinoma: a study of lymphocyte response to phytohemagglutinin.
Topics: Adenocarcinoma; Adenocarcinoma, Bronchiolo-Alveolar; Adult; Aged; Carcinoma; Carcinoma, Bronchogenic | 1972 |
Neuraminidase and cell viability: failure to detect cytotoxic effects with dye-exclusion techniques.
Topics: Adenocarcinoma, Bronchiolo-Alveolar; Animals; Antigens, Neoplasm; Cell Division; Cell Survival; Cell | 1974 |